First Turn Management »

Transmedics Group shares owned by First Turn Management

Quarter-by-quarter ownership of Transmedics Group (TMDX) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Transmedics Group

Tip: Access up to 7 years of quarterly data

All positions including Transmedics Group held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transmedics Group by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $22M 297k 73.94
2023-12-31 $26M 323k 78.93

More positions owned by First Turn Management

Shockwave Med (SWAV)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Xenon Pharmaceuticals (XENE)
Sarepta Therapeutics (SRPT)
Axsome Therapeutics (AXSM)
Dex (DXCM)
Immunocore Hldgs Ads (IMCR)
Apogee Therapeutics (APGE)
Vertex Pharmaceuticals Incorporated (VRTX)
Mirum Pharmaceuticals (MIRM)
Biohaven (BHVN)
Krystal Biotech (KRYS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Transmedics Group (TMDX)

View all positions for First Turn Management

Top funds holding Transmedics Group

Vanguard Group
Fred Alger Management
Arrowpoint Asset Management
Eventide Asset Management
Credit Suisse
Sandhill Capital Partners
First Light Asset Management
Allspring Global Investments Holdings
Mackenzie Financial
Bank of New York Mellon
Emerald Advisers
Bellevue Group
Daniel D. Thurber
Emerald Mutual Fund Advisers, Trust
Goldman Sachs Group

View all funds holding Transmedics Group